We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Relistor for Treatment of Opioid-Induced Constipation
FDA Approves Relistor for Treatment of Opioid-Induced Constipation
The FDA has approved a new drug co-developed by Valeant Pharmaceuticals and Progenics Pharmaceuticals that treats opioid-induced constipation in adults.